Sale!

MPZ Gene CMT4E Genetic Test

4,400 د.إ

-21%

The MPZ Gene CMT4E Genetic Test is a specialized diagnostic procedure designed to identify mutations in the MPZ gene, which are associated with Charcot-Marie-Tooth disease type 4E (CMT4E). CMT4E is a rare form of Charcot-Marie-Tooth disease, a neurological disorder that affects the peripheral nerves, leading to muscle weakness and sensory problems. The MPZ gene plays a crucial role in the functioning and structure of peripheral nerves, and mutations in this gene can disrupt nerve function, resulting in the symptoms of CMT4E.

This genetic test involves analyzing the patient’s DNA to look for specific mutations in the MPZ gene that are known to cause CMT4E. It is a critical tool for confirming a diagnosis of CMT4E, enabling healthcare providers to tailor treatment plans and management strategies to the individual’s condition. Furthermore, identifying the mutation can also provide valuable information for family planning and genetic counseling for affected families.

The MPZ Gene CMT4E Genetic Test is available at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the test is 4400 AED. By offering this test, DNA Labs UAE aims to provide patients and their families with access to crucial information that can significantly impact the management of Charcot-Marie-Tooth disease type 4E, ultimately improving patient outcomes and quality of life.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

MPZ Gene CMT4E Genetic Test

Welcome to DNA Labs UAE, a leading genetic lab offering the MPZ Gene CMT4E Genetic Test. In this blog, we will discuss the cost, symptoms, diagnosis, and other important details of this test.

Test Name: MPZ Gene CMT4E Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information

Before undergoing the MPZ Gene CMT4E Genetic Test, it is important to provide the clinical history of the patient. A Genetic Counselling session may be conducted to draw a pedigree chart of family members affected with MPZ Gene CMT4E.

Test Details

The MPZ gene is associated with Charcot-Marie-Tooth disease type 4E (CMT4E), a rare genetic disorder that affects the peripheral nervous system and causes muscle weakness and atrophy in the hands and feet.

NGS (next-generation sequencing) genetic testing is a method used to sequence the entire MPZ gene and identify any mutations or variations that may be causing CMT4E. This type of testing can provide a more accurate diagnosis and help determine the best course of treatment for individuals with CMT4E.

NGS testing is typically performed using a blood or saliva sample and can be ordered by a healthcare provider who suspects CMT4E based on an individual’s symptoms and family history. Results from NGS testing can take several weeks to months to obtain and may require additional confirmatory testing.

It is important to note that genetic testing for CMT4E is not always necessary or recommended for all individuals with symptoms of the disorder. A healthcare provider can help determine if genetic testing is appropriate and provide guidance on the risks and benefits of testing.

Test Name MPZ Gene CMT4E Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for MPZ Gene CMT4E NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with MPZ Gene CMT4E
Test Details

The MPZ gene is associated with Charcot-Marie-Tooth disease type 4E (CMT4E), a rare genetic disorder that affects the peripheral nervous system and causes muscle weakness and atrophy in the hands and feet.

NGS (next-generation sequencing) genetic testing is a method used to sequence the entire MPZ gene and identify any mutations or variations that may be causing CMT4E. This type of testing can provide a more accurate diagnosis and help determine the best course of treatment for individuals with CMT4E.

NGS testing is typically performed using a blood or saliva sample and can be ordered by a healthcare provider who suspects CMT4E based on an individual’s symptoms and family history. Results from NGS testing can take several weeks to months to obtain and may require additional confirmatory testing.

It is important to note that genetic testing for CMT4E is not always necessary or recommended for all individuals with symptoms of the disorder. A healthcare provider can help determine if genetic testing is appropriate and provide guidance on the risks and benefits of testing.